Evidence map›Paper›PMID 39898163›Full record

ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2025

Palliative endoscopic debulking treatment of canine nasal carcinoma - 35 cases (2016 to 2019): A retrospective multicentric study.

Enrico Bottero, Riccardo Ferriani, Alessio Pierini, Emanuele Mussi, Pietro Ruggiero, Simona Astorina, Davide De Lorenzi, Fabiano Raponi

Abstract readMulticenter Study
In one paragraph

Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Enrico BotteroEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Riccardo FerrianiEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Alessio PieriniEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Emanuele MussiEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Pietro RuggieroEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Simona AstorinaEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Davide De LorenziEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).
Fabiano RaponiEndovet Professional Association, via Antonio Oroboni, 8-00149, Rome, Italy (Bottero, Ferriani, Mussi, Ruggiero, Astorina, Raponi); Centro Veterinario Dott.ri Pisani-Carli-Chiodo, Via Togliatti 8/10, 19034, Luni Mare, (SP), Italy (Pierini); Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Veterinary Hospital I Portoni Rossi, Zola Predosa, Bologna, Italy (De Lorenzi).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This retrospective study investigated the palliative efficacy of endoscopic diode laser and forceps debulking (EDLFD) for managing nasal carcinoma in dogs. Animals and procedure: Thirty-five dogs with histopathological diagnosis of nasal carcinoma that underwent EDLFD treatment were included. Descriptive statistics were reported regarding age, sex, neutering status, weight, body condition score, epistaxis, sneezing, stertor, reverse sneezing, nasal discharge, facial deformity, tumor laterality, modified Adams staging, quality of life at presentation, histotypes, EDLFD duration, adjuvant metronomic chemotherapy, and survival time. Results: Eighteen (51%) dogs exhibited clinical signs persisting for > 3 mo, with 80% failing to respond to previous medical treatments. Unilateral discharge was the most common complaint. Tumor location was categorized as nasal in 43% of cases (unilateral: 37% and bilateral: 6%) and as nasal and nasopharyngeal in 57%. No major intraoperative or postoperative complications were observed associated with EDLFD. The median survival time was 336 d. A clinical benefit > 50% was observed 3 mo after EDLFD. Conclusion and clinical relevance: We concluded that EDLFD was a viable palliative approach for nasal carcinoma in dogs, offering promising results in improving quality of life.

Indexed as

CarcinomaCytoreduction Surgical ProceduresDog DiseasesEndoscopyNose NeoplasmsPalliative CareAnimalsDogsFemaleMaleRetrospective StudiesTreatment Outcome

Identifiers

PMID39898163
PMCPMC11770626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.